USA - NASDAQ:CYXT - US23284C1027 - Common Stock
ChartMill assigns a Buy % Consensus number of 75% to CYXT. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-03-22 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2023-03-20 | TD Cowen | Downgrade | Outperform -> Market Perform |
| 2023-03-17 | Credit Suisse | Maintains | Outperform |
| 2023-02-07 | Credit Suisse | Maintains | Outperform |
| 2022-12-22 | Truist Securities | Maintains | Buy |
| 2022-12-14 | Exane BNP Paribas | Initiate | Underperform |
| 2022-12-01 | Citigroup | Maintains | Buy |
| 2022-11-09 | UBS | Maintains | Neutral |
| 2022-11-09 | Raymond James | Maintains | Outperform |
| 2022-09-20 | Truist Securities | Maintains | Buy |
| 2022-08-24 | Citigroup | Upgrade | Neutral -> Buy |
| 2022-06-08 | Truist Securities | Maintains | Buy |
| 2022-06-06 | RBC Capital | Maintains | Outperform |
| 2022-04-07 | Credit Suisse | Initiate | Outperform |
| 2022-01-03 | UBS | Initiate | Neutral |
| 2021-12-16 | RBC Capital | Initiate | Outperform |
| 2021-12-10 | Truist Securities | Initiate | Buy |
| 2021-12-02 | Citigroup | Maintains | Neutral |
| 2021-11-18 | Raymond James | Initiate | Outperform |
11 analysts have analysed CYXT and the average price target is 1.34 USD. This implies a price increase of 1959.62% is expected in the next year compared to the current price of 0.065.
The consensus rating for CYXTERA TECHNOLOGIES INC (CYXT) is 74.5455 / 100 . This indicates that analysts generally have a positive outlook on the stock.